Published On May 18, 2023
Dr. Susan Reed discusses the first neurokinin 3 (NK3) receptor antagonist approved by FDA to treat moderate to severe hot flashes that works by binding to and blocking the activities of the NK3 receptor, the brain’s thermoregulator. (www.menopause.org)
show more